BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 17374389)

  • 21. Placebo-controlled community trial of four cycles of single-dose diethylcarbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India.
    Das PK; Ramaiah KD; Vanamail P; Pani SP; Yuvaraj J; Balarajan K; Bundy DA
    Trans R Soc Trop Med Hyg; 2001; 95(3):336-41. PubMed ID: 11491011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
    Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P
    Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annual single-dose diethylcarbamazine plus ivermectin for control of bancroftian filariasis: comparative efficacy with and without vector control.
    Reuben R; Rajendran R; Sunish IP; Mani TR; Tewari SC; Hiriyan J; Gajanana A
    Ann Trop Med Parasitol; 2001 Jun; 95(4):361-78. PubMed ID: 11454246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis.
    Stolk WA; VAN Oortmarssen GJ; Pani SP; DE Vlas SJ; Subramanian S; DAS PK; Habbema JD
    Am J Trop Med Hyg; 2005 Nov; 73(5):881-7. PubMed ID: 16282298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance of lymphatic filariasis after stopping ten years of mass drug administration in rural communities in south India.
    Ramaiah KD; Vanamail P
    Trans R Soc Trop Med Hyg; 2013 May; 107(5):293-300. PubMed ID: 23442572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
    Regu K; Showkath Ali MK; Rajendran R; Koya SM; Ganesh B; Dhariwal AC; Lal S
    J Commun Dis; 2006 Dec; 38(4):333-8. PubMed ID: 17913209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerability and efficacy of single dose diethylcarbamazine (DEC) alone or co-administration with Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India.
    Pani SP; Reddy GS; Vanamail P; Venkatesvarlou N; Das LK; Vijayan AP
    J Commun Dis; 2004 Dec; 36(4):240-50. PubMed ID: 16506546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of floating layers of polystyrene beads to control populations of the filaria vector Culex quinquefasciatus.
    Curtis CF; Malecela-Lazaro M; Reuben R; Maxwell CA
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S97-104. PubMed ID: 12625923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of ivermectin drug combinations on Pediculus humanus capitis infestation in primary schoolchildren of south Indian rural villages.
    Munirathinam A; Sunish IP; Rajendran R; Tyagi BK
    Int J Dermatol; 2009 Nov; 48(11):1201-5. PubMed ID: 20064176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination of diurnally sub-periodic Wuchereria bancrofti in Andaman and Nicobar Islands, India, using mass DEC-fortified salt as a supplementary intervention to MDA.
    Shriram AN; Premkumar A; Krishnamoorthy K; De A; Paul SK; Subramanian S; Vijayachari P; Jambulingam P
    Parasitol Res; 2020 May; 119(5):1467-1483. PubMed ID: 32219550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme.
    Ramaiah KD; Thiruvengadam B; Vanamail P; Subramanian S; Gunasekaran S; Nilamani N; Das PK
    Trop Med Int Health; 2009 Aug; 14(8):870-6. PubMed ID: 19552662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single versus repeated doses of ivermectin and diethylcarbamazine for the treatment of Wuchereria bancrofti var. pacifica microfilaremia. Results at 12 months of a double-blind study.
    Cartel JL; Spiegel A; Nguyen Ngnoc L; Cardines R; Plichart R; Martin PM; Roux JF
    Trop Med Parasitol; 1991 Dec; 42(4):335-8. PubMed ID: 1796228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.
    Ramzy RM; El Setouhy M; Helmy H; Ahmed ES; Abd Elaziz KM; Farid HA; Shannon WD; Weil GJ
    Lancet; 2006 Mar; 367(9515):992-9. PubMed ID: 16564361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tolerability and efficacy of a three-age class dosage schedule of Diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphatic filariasis (LF).
    Pani SP; Das LK; Vanamail P
    J Commun Dis; 2005 Mar; 37(1):12-7. PubMed ID: 16637395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
    Sunish IP; Kalimuthu M; Rajendran R; Munirathinam A; Ashok Kumar V; Nagaraj J; Tyagi BK
    Parasitol Int; 2015 Feb; 64(1):1-4. PubMed ID: 25205435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand.
    Bhumiratana A; Koyadun S; Srisuphanunt M; Satitvipawee P; Limpairojn N; Gaewchaiyo G
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):390-407. PubMed ID: 15916046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.
    Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Thakur PA; Gupta A; Ingole NS; Lazdins-Helds JK
    Parasitol Res; 2017 Oct; 116(10):2683-2694. PubMed ID: 28785847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study to compare the effect of adding 12 days DEC regimen to 6 years annual mass drug administration to eliminate microfilaraemia infection in the community in rural Kanpur, Uttar Pradesh, India.
    Kumar A; Sachan P; Bajpei A; Singh T
    J Commun Dis; 2013; 45(1-2):33-40. PubMed ID: 25141552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of bi-annual administration of DEC in the control of bancroftian filariasis.
    Balakrishnan N; Ramaiah KD; Pani SP
    J Commun Dis; 1992 Jun; 24(2):87-91. PubMed ID: 1344177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
    de Kraker ME; Stolk WA; van Oortmarssen GJ; Habbema JD
    Trop Med Int Health; 2006 May; 11(5):718-28. PubMed ID: 16640625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.